Patents by Inventor Steven Jones

Steven Jones has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160251353
    Abstract: Polymorphic forms of Compound (1) or a pharmaceutically acceptable salt thereof, wherein Compound (1) is represented by the following structural formula: are Form A of HCl salt of Compound (1).½H2O, Form F of HCl salt of Compound (1).3H2O, Form D of HCl salt of Compound (1), Form A of Compound (1), and Form A of tosylate salt of Compound (1). Such polymorphic forms are employed for treating influenza, inhibiting the replication of influenza viruses, or reducing the amount of influenza viruses in a biological sample or in a subject.
    Type: Application
    Filed: May 10, 2016
    Publication date: September 1, 2016
    Inventors: Kwame W. Nti-Addae, Michael Waldo, Simon Adam O'Neil, John Gregg Van Alsten, Dainius Macikenas, Praveen Mudunuri, Yi Shi, Mark Willem Ledeboer, Valdas Jurkauskas, Ales Medek, Steven Jones, Randal Byrn, Mohammed Asmal, Sarah Marie Robertson, Wanjung Tsai
  • Publication number: 20160234375
    Abstract: A solution to mitigate personal, organizational, and network wide risks and exposure from damages and harm related to distracted driving. The invention includes a system, method, and devices that enforce a safe messaging protocol that prevents communications from being transmitted to recipients while the recipients are driving, piloting, operating heavy machinery or otherwise endangered from being distracted from incoming communications.
    Type: Application
    Filed: February 11, 2015
    Publication date: August 11, 2016
    Inventors: Steven Jones, Paul Gaylie
  • Publication number: 20160161454
    Abstract: Analyte separation systems for use in conjunction with chromatography separation devices and techniques are described. Disclosed systems include modular components that can provide for individualized design of separation schemes to better fit the needs of the user. In addition, the systems can be automated for efficient use of time. The system can include a mixing module for combination of fractions with an agent that can improve the recovery of the analyte from the fraction. Other modules can remove materials from the fluid flow through the system as waste or for recapture. Additional modules can be combined so as to provide parallel processing of multiple streams, which can further improve efficiency of the system.
    Type: Application
    Filed: December 7, 2015
    Publication date: June 9, 2016
    Inventors: Gregory Steven Jones, Feng Chen
  • Publication number: 20160152614
    Abstract: Methods of inhibiting the replication of influenza viruses in a biological sample or patient, of reducing the amount of influenza viruses in a biological sample or patient, and of treating influenza in a patient, comprises administering to said biological sample or patient an effective amount of a compound represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (IA) are as described herein. A compound is represented by Structural Formula (IA) or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (IA) are as described herein. A pharmaceutical composition comprises an effective amount of such a compound or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, adjuvant or vehicle.
    Type: Application
    Filed: November 2, 2015
    Publication date: June 2, 2016
    Inventors: Paul S. Charifson, Michael P. Clark, Upul K. Bandarage, Randy S. Bethiel, John J. Court, Hongbo Deng, Ioana Davies, John P. Duffy, Luc J. Farmer, Huai Gao, Wenxin Gu, Dylan H. Jacobs, Joseph M. Kennedy, Mark W. Ledeboer, Brian Ledford, Francois Maltais, Emanuele Perola, Tiansheng Wang, M. Woods Wannamaker, Randal Byrn, Yi Zhou, Chao Lin, Min Jiang, Steven Jones, Ursula A. Germann, Francesco G. Salituro, Ann Dak-Yee Kwong
  • Publication number: 20160151492
    Abstract: Described herein are a number of Ebola monoclonal antibodies.
    Type: Application
    Filed: December 28, 2015
    Publication date: June 2, 2016
    Inventors: Steven Jones, Xiangguo Qiu, Heinz Feldmann, Ute Stroeher
  • Publication number: 20160145437
    Abstract: The present application is directed to combination effect pigments comprising an effect pigment and carbon black, wherein the carbon black is adherently deposited on the effect pigment interposed within the substrate and at least one subsequent layer of the effect pigment. This structure of the combination effect pigment results in advantageous non-staining properties of the pigment and maximizes color effects of the carbon black.
    Type: Application
    Filed: December 22, 2014
    Publication date: May 26, 2016
    Inventors: Lizzabeth Ponce, Geoffrey Johnson, Louis R. Cerce, Steven Jones, Curtis J. Zimmermann
  • Publication number: 20160145438
    Abstract: The present application is directed to a combination effect pigment comprising a platy substrate, an outer layer disposed above the platy substrate, and carbon black, wherein the carbon black is disposed above the substrate and is entrapped by the outer layer.
    Type: Application
    Filed: November 23, 2015
    Publication date: May 26, 2016
    Inventors: Lizzabeth Ponce, Geoffrey Johnson, Louis R. Cerce, Steven Jones, Curtis Zimmermann, Benjamin Georg Robert Mohr, Charmain Hoffstead-Fordyce
  • Patent number: 9345708
    Abstract: Methods of inhibiting the replication of influenza viruses in a biological sample or patient, of reducing the amount of influenza viruses in a biological sample or patient, and of treating influenza in a patient, comprises administering to said biological sample or patient an effective amount of a compound represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (IA) are as described herein. A compound is represented by Structural Formula (IA) or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (IA) are as described herein. A pharmaceutical composition comprises an effective amount of such a compound or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, adjuvant or vehicle.
    Type: Grant
    Filed: June 16, 2014
    Date of Patent: May 24, 2016
    Assignee: Vertex Pharmaceuticals Incorporated
    Inventors: Paul S. Charifson, Michael P. Clark, Upul K. Bandarage, Randy S. Bethiel, John J. Court, Hongbo Deng, Ioana Davies, John P. Duffy, Luc J. Farmer, Huai Gao, Wenxin Gu, Dylan H. Jacobs, Joseph M. Kennedy, Mark W. Ledeboer, Brian Ledford, Francois Maltais, Emanuele Perola, Tiansheng Wang, M. Woods Wannamaker, Randal Byrn, Yi Zhou, Chao Lin, Min Jiang, Steven Jones, Ursula A. Germann, Francesco G. Salituro, Ann Dak-Yee Kwong
  • Publication number: 20160075467
    Abstract: A blank configured to form a package is provided. The blank may include a bottom panel, a top panel, and an overlapping panel having an edge region and an adjoining region positioned between the edge region and the top panel. The adjoining region of the overlapping panel overlaps and attaches to the bottom panel to form a compartment when formed into a package. The compartment may be employed to store a consumable product, such as cartridges for an aerosol delivery device. A related method for forming the blank into the package is also provided.
    Type: Application
    Filed: September 11, 2014
    Publication date: March 17, 2016
    Inventors: Jerry Wayne Pipes, Wesley Steven Jones
  • Patent number: 9249214
    Abstract: Described herein are a number of Ebola monoclonal antibodies.
    Type: Grant
    Filed: July 12, 2013
    Date of Patent: February 2, 2016
    Assignee: Her Majesty the Queen in the Right of Canada as Represented by the Minister of Health
    Inventors: Steven Jones, Xiangguo Qiu, Heinz Feldmann, Ute Stroeher
  • Patent number: 9208006
    Abstract: A Recovery Maturity Model (RMM) is used to determine whether a particular Information Technology (IT) production environment can be expected, with some level of confidence, to successfully execute a test for disaster recovery (DR). The RMM provides a quantitative analysis in terms of the extent to which best practices are seen to have been implemented as a set of categories for elements of the environment and multiple elements for each category. A summation of the scoring elements, which may be a weighted summation, results in an overall quantitative metric which is then used to control whether or not testing will proceed.
    Type: Grant
    Filed: March 11, 2013
    Date of Patent: December 8, 2015
    Assignee: SUNGARD AVAILABILITY SERVICES, LP
    Inventors: Steven Jones, Jose Maldonado
  • Publication number: 20150344677
    Abstract: A high chroma effect pigment includes a platelet substrate and an optical coating formed on the platelet substrate. The optical coating includes a first high refractive index layer, a second high refractive index layer on the first high refractive index layer, and a diffused third material having a range of diffusion between 100% to partial diffusion in the first high refractive index layer, the second high refractive index layer, or both the first and the second high refractive index layers. The first and second high refractive index layers independently have a refractive index of about >1.65. The diffused third material is SiO2 or a metal oxide is different than the first and second high refractive index layers.
    Type: Application
    Filed: May 21, 2015
    Publication date: December 3, 2015
    Inventors: Steven Jones, Meaghan Clark McGuire, James Sioss, Christopher Sichmeller, Martin Saltzman
  • Publication number: 20150344546
    Abstract: Described herein are a number of Ebola monoclonal antibodies.
    Type: Application
    Filed: July 12, 2013
    Publication date: December 3, 2015
    Inventors: Steven Jones, Xiangguo Qiu, Heinz Feldmann, Ute Stroeher
  • Patent number: 9145454
    Abstract: Described herein are a number of Ebola monoclonal antibodies.
    Type: Grant
    Filed: July 12, 2013
    Date of Patent: September 29, 2015
    Assignee: Her Majesty the Queen in the Right of Canada as Represented by the Minister of Health
    Inventors: Steven Jones, Xiangguo Qiu, Heinz Feldmann, Ute Stroeher
  • Publication number: 20150232538
    Abstract: Described herein are a number of Ebola monoclonal antibodies.
    Type: Application
    Filed: July 12, 2013
    Publication date: August 20, 2015
    Inventors: Steven Jones, Xiangguo Qiu, Heinz Feldmann, Ute Stroeher
  • Publication number: 20150209654
    Abstract: The invention is directed to a reconfigurable gaming tables and playing cards, such as card devices including thin, planar display devices in communication with a processing device for randomly selecting card images stored in a data storage device for display on the display devices.
    Type: Application
    Filed: November 12, 2014
    Publication date: July 30, 2015
    Applicant: DEQ Systems Corp.
    Inventors: Steven Jones, Kyle Kornegay, Kurt Hilts
  • Publication number: 20150201674
    Abstract: The present disclosure relates to electronic smoking articles exhibiting improved moisture control of a reservoir contained therein. The reservoir can be formed of fibrous materials, such as cellulose acetate fiber, thermoplastic fiber, non-thermoplastic fiber, or a combination thereof. The disclosure further provides methods for forming electronic smoking articles and methods of packaging electronic smoking articles (including cartridges thereof) so as to improve moisture control of the reservoir.
    Type: Application
    Filed: January 17, 2014
    Publication date: July 23, 2015
    Applicant: R.J. Reynolds Tobacco Company
    Inventors: Grady Lance Dooly, Stephen Benson Sears, Karen V. Williams, Gary M. Dull, Steven L. Worm, Wesley Steven Jones, Steven Lee Alderman, Paul A. Brinkley, Jack Gray Flinchum
  • Patent number: D747878
    Type: Grant
    Filed: March 13, 2014
    Date of Patent: January 26, 2016
    Assignee: R. J. Reynolds Tobacco Company
    Inventors: Hung Mach, Mitchell Tung, Wesley Steven Jones, Donald Leon Robertson
  • Patent number: D748498
    Type: Grant
    Filed: May 2, 2014
    Date of Patent: February 2, 2016
    Assignee: R.J. Reynolds Tobacco Company
    Inventors: Jerry Wayne Pipes, Wesley Steven Jones, Donald Leon Robertson, Steven A. Hasselbach, Jr.
  • Patent number: D756223
    Type: Grant
    Filed: May 2, 2014
    Date of Patent: May 17, 2016
    Assignee: R.J. Reynolds Tobacco Company
    Inventors: Jerry Wayne Pipes, Wesley Steven Jones, Donald Leon Robertson, Steven A. Hasselbach, Jr.